Showing results (71-80 of 220) with videos related to
Sort By:
Pageof 22
Anticancer Research|May 1, 1992
A role for plasma membrane potential in doxorubicin--induced cytotoxicityM Nishiyama, K Aogi, S Saeki, et al.Acta Pathologica Japonica|November 1, 1993
A role of VLA-6 laminin receptor in invasion of breast carcinomaK Arihiro, K Inai, K Kurihara, et al.Clinical and Experimental Immunology|December 1, 1988
Role of the spleen in immunosuppression of gastric cancer: predominance of suppressor precursor and suppressor inducer T cells in the recirculating spleen cellsT Toge, K Kuroi, H Kuninobu, et al.The Japanese Journal of Surgery|July 1, 1985
Effects of intraperitoneal administration of OK-432 for patients with advanced cancerT Toge, H Yamada, K Aratani, et al.Lung Cancer (Amsterdam, Netherlands)|November 1, 1996
Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cellsM Toi-Scott, C L Jones, M A KaneActa Pathologica Japonica|June 1, 1993
Myxoma of the breast: report of a case with unique histological and immunohistochemical appearancesK Arihiro, K Inai, K Kurihara, et al.The Japanese Journal of Surgery|March 1, 1987
Relationship of the distribution of Leu-2+ cells with suppressor cell activities in the spleen and lymph-nodes from gastric cancerT Toge, Y Seto, K Kuroi, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 1, 1995
Sweat gland carcinoma in a human immunodeficiency virus-infected patientM Toi, L Kauffman, L Peterson, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1997
[The feasibility of CEF (cyclophosphamide, epirubicin, 5-FU) regimen in the adjuvant setting of primary breast cancer]S Honda, M Toi, S Shimizu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Current directions for COX-2 inhibition in breast cancerL W C Chow, W T Y Loo, M ToiPageof 22